Images List Premium Download Classic

Analogue

Analogue-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
Sarepta Therapeutics, Inc.
July 13, 2017 - N°20170198287

Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mrna splice products produces beneficial therapeutic effects.
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
Idenix Pharmaceuticals Llc
July 13, 2017 - N°20170198005

Provided herein are compounds, compositions and methods for the treatment of flaviviridae infections, including hcv infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are 2′-dichloro or 2′-fluoro-2′-chloro nucleoside analogue compounds which display remarkable efficacy ...
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
Amphastar Pharmaceuticals Inc.
July 13, 2017 - N°20170196942

A high-purity inhalable insulin material, used for preparing a pulmonary pharmaceutical product, includes insulin particles having a particle size at the micrometer level and having the following characteristics: (i) the purity of insulin is not less than 96% on the dried basis; (ii) the total amount of insulin-related impurities is not more than 2%; (iii) the total amount of solvent impurities, which ...
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
Stealth Biotherapeutics Corp
July 13, 2017 - N°20170196933

Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of a therapeutic biological molecule, and/or naturally or artificially occurring derivatives, analogues, or pharmaceutically acceptable salts thereof, alone or in combination with one or more active agents (e. G., an aromatic-cationic peptide). The present technology provides compositions related to aromatic-cationic peptides ...
Tgr5 agonist complexes for treating diabetes and cancer
City Of Hope
July 13, 2017 - N°20170196890

Provided herein are complexes of metformin or metformin analogues and a tgr5 ligand that are useful in treating diseases including diabetes, cardiovascular disease, and cancer.
Novel glucagon analogues
Novo Nordisk A/s
July 06, 2017 - N°20170190757

The present invention relates to novel peptide compounds which have a protracted profile of action and improved solubility and stability, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are ...
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Dendrimer-drug conjugates
Starpharma Pty Ltd
July 06, 2017 - N°20170189543

The present invention generally relates to macromolecules of dendrimer-drug conjugates. In particular, the invention relates to macromolecules comprising a pharmaceutically active agent, such as a protein or peptide, attached to a core of a dendrimer derived from branched building units, such as lysine or lysine analogues. The invention also relates to the synthesis of the dendrimers and macromolecules, and the ...
Method of drug delivery for pth, pthrp and related peptides
3m Innovative Properties Company, A Wholly Owned Subsidiary Of 3m Company
July 06, 2017 - N°20170189493

The present invention provides compositions, devices, methods and processes related to the intradermal delivery of pthrp and pthrp analogues, particularly [glu22,25, leu23,28,31, aib29, lys26,30]hpthrp(1-34)nh2.
Oxyntomodulin analogue
3m Innovative Properties Company, A Wholly Owned Subsidiary Of 3m Company
June 29, 2017 - N°20170183383

Provided is an oxyntomodulin analogue. The analogue comprises gcgr and glp-1r dual agonist activity, improved enzymolysis stability and biological activity, and no adverse reactions. The analogue can be used to prepare medication for treating hyperphagia, obesity and diabetes.
Omega-3 analogues
The University Of Technology Sydney
June 29, 2017 - N°20170183297

The present invention relates to new omega-3 fatty acid analogues and to their use in cancer therapy, including anti-metastatic therapy.
Polymer conjugate for delivery of a bioactive agent
Polyactiva Pty Ltd
June 29, 2017 - N°20170182173

The present invention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety comprising prostaglandin analogues. The present invention also relates to methods for preparing the polymer conjugates using click chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the ...
Stealth Biotherapeutics Corp
June 29, 2017 - N°20170182117

Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of tsm, and/or naturally or artificially occurring derivatives, analogues, or pharmaceutically acceptable salts thereof, alone or in combination with one or more active agents (e. G., an aromatic-cationic peptide). The present technology provides compositions related to aromatic-cationic peptides linked to tsm ...
Method and apparatus for generating phase shift control signals
Nxp Usa, Inc.
June 22, 2017 - N°20170180169

A phase shifter controller arranged to generate phase shift control signals for at least one phase shifter. The phase shifter controller is arranged to receive a first phase value θ1, receive a second phase value θ2, and output phase shift control signals. The phase shifter controller comprises a digital synthesizer arranged to compute a first digital phase shift ...
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Clock frequency reduction for an electronic device
Arm Limited
June 22, 2017 - N°20170177055

An electronic device (20) has a clock path (24) for propagating a clock signal and a clock propagating element (26) on the clock path. An analogue element (30) coupled to the clock path (24) varies, in dependence on an analogue level of a first signal (32), a switching delay for the clock propagating element (26) to trigger a transition of the clock signal. The first signal is ...
Novel methods and kits for detecting a rifamycin, or derivative or analogue thereof
Drexel University
June 22, 2017 - N°20170176475

The present invention includes methods of identifying one or more rifamycins, or analogues or metabolites thereof, that are present in a biological sample from a subject that is being administered a rifamycin-containing medication. The present invention further includes methods of adjusting and/or optimizing the dosage regime for a rifamycin-containing medication.
Alpha- and gamma-msh analogues
Txp Pharma Gmbh
June 22, 2017 - N°20170174738

The present invention provides peptide analogues of α-msh and γ-msh, comprising the amino acid sequence of human α-msh or γ-msh, or variants thereof, and having a branched amino acid probe in the n-terminal part of the peptide.
Processes for the preparation of oxytocin analogues
Hoffmann-la Roche Inc.
June 22, 2017 - N°20170174725

Provided herein is a process for the preparation of oxytocin receptor agonists that have the potential to be used for the treatment of neurological disorders.
Spiro-oxazines, indolinones and preparation thereof
Council Of Scientific & Industrial Research
June 22, 2017 - N°20170174706

The present invention relates to novel spiro-oxazine analogues of formula-i and indolinone compounds of formula-ii or positional isomers, or stereoisomers, or derivatives, or pharmaceutically acceptable salt thereof. Formula-i formula-ii further the invention provides transition-metal free multicomponent reaction (mcr) process for the preparation of said compounds of formula-i and ii using aryne precursor, n-substituted isatin and n-heteroaromatic compound as the nucleophile, ...
Synthetic route to anhydroryanodol, ryanodol and structural analogues
California Institute Of Technology
June 22, 2017 - N°20170174648

This disclosure is related to methods for producing anhydroryanodol, ryanodol, or analogues thereof and novel compounds prepared thereby.
Treatment of urinary tract infection
Biomedicals Sweden Ab
June 22, 2017 - N°20170173058

The embodiments relate to compositions useful in the treatment, inhibition or prevention of urinary tract infection in a subject. The compositions comprise a ph increasing agent, a ph decreasing agent and man nose or an analogue thereof. The ph increasing agent and the ph decreasing agent are provided to be alternately administered to the subject.
Particulate materials
Nektar Therapeutics
June 22, 2017 - N°20170173006

Embodiments of the invention relate to particles of active substances, methods for preparing the particles, formulations containing the particles, and metered dose inhalers containing such particles or formulations. In one embodiment, a composition of an aerosol formulation is provided and contains a particulate active substance of non-micronized, solid particles having a mass median aerodynamic diameter of less than 10 μ...
Loading